Precision Biosciences Inc
DTIL· Nasdaq
DTILPrecision Biosciences Inc
Filed May 15, 2020 · 10-Q · 45 days after period end · 0001564590-20-025635
| Metric | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|
| Revenue | $7.00M | $5.46M | $1.53M |
| Net Income | -$26.84M | -$31.78M | -$9.01M |
| EPS Diluted | -$0.52 | -$1.99 | -$0.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 15, 2020 · 45 d after period end
